Key facts
- It has raised $1.0M across 1 recorded rounds; the latest was Mezzanine ($150K) in May 2025.
- AGILE GxP Technologies has filed 4 Form Ds with the SEC since 2024, most recently May 2025 ($825K sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for AGILE GxP Technologies
Funding rounds
1 roundsAbout AGILE GxP Technologies
Operator of a biopharmaceutical company based in Providence, Rhode Island. The company offers new therapies to patients by providing transformative technology intended to provide services to patients with automated integration, centralized process control, cross-platform communication, and more, enabling clients to achieve faster, more reliable, and compliant manufacturing processes.
- Sector
- Healthcare
- HQ
- Providence, RI, United States
- Founded
- 2021
- Website
- agilegxp.tech/
- Ownership
- Privately Held (backing)
AGILE GxP Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AGILE GxP Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AGILE GxP Technologies in its N-PORT filings yet. We sweep new filings monthly.